Etirinotecan pegol: Survival advantage over standard of care drugs in a model of brain metastases of breast cancer

Shah, N; Mohammad, AS; Adkins, CE; Dolan, EL; Griffith, J; Jagannathan, R; Hoch, U; Lockman, PR

CANCER RESEARCH, 2017; 77 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索